Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9354
Peer-review started: April 1, 2022
First decision: June 16, 2022
Revised: June 29, 2022
Accepted: August 5, 2022
Article in press: August 5, 2022
Published online: September 16, 2022
Processing time: 153 Days and 11.9 Hours
Epithelioid trophoblastic tumor (ETT) is a special type of gestational trophoblastic tumor. However, its pathogenesis has been incompletely elucidated. ETT rarely occurs in the ovaries and fallopian tubes, unlike placental site trophoblastic tumor, requiring a histopathological biopsy and immunohistochemistry for further diagnosis.
A 29-year-old woman with irregular vaginal bleeding and elevated serum chorionic gonadotropin (β-hCG) levels presented similar symptoms to ectopic pregnancy. Transvaginal ultrasound revealed abnormal echoes of the left adnexa. Postoperatively, the pathology of the left ovary and fallopian tube was reported as ETT. The patient was followed up with regular hCG measurements and ultr
For women of childbearing age with elevated serum β-hCG levels, practitioners should consider ETT and be alert to the poor prognosis of the disease. After surgery, the patient's condition should be closely observed to prevent recurrence and metastasis. Postoperative chemotherapy is only helpful for treating the disease to a certain extent.
Core Tip: Epithelioid trophoblastic tumor (ETT) is a rare type of intermediate trophoblastic tumor. Clinical manifestations include irregular vaginal bleeding and changing serum chorionic gonadotropin levels. This case highlights the ultimate importance of histopathological biopsy and immunohistochemistry. Survival outcomes from this disease are high but the tumor can easily relapse and metastasize. Therefore, long-term follow-up is important for the future diagnosis and treatment of ETT.
